Monash University

Embargoed and Restricted Access

Reason: Under embargo until February 2024. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library.

Functionalization of porous silicon nanovectors for triple-negative breast cancer treatment

posted on 2023-02-03, 05:02 authored by ANKIT MALHOTRA
Triple-negative breast cancer (TNBC) is the most challenging breast cancer subtype to treat, and there is no viable targeted treatment strategy. Conventional TNBC chemotherapy is limited by its nonspecific damage to normal tissues and organs. This thesis describes the development of a novel porous silicon drug-delivery nanotherapeutics, which is TNBC-specific and biodegradable. The result indicates an enhanced tumor accumulation of nanoformulation inducing selective TNBC killing without much damage to normal tissues. The potential subcellular mechanisms of the TNBC targeting are clarified to understand the targeting mechanism. This study builds a compelling case for taking TNBC therapy from bench to bedside.


Campus location


Principal supervisor

Nicolas Hans Voelcker

Additional supervisor 1

Anna Cifuentes-Rius

Additional supervisor 2

Wing Yin Tong

Additional supervisor 3

Kylie Michelle Wagstaff

Year of Award


Department, School or Centre

Drug Delivery, Disposition and Dynamics


Doctor of Philosophy

Degree Type



Faculty of Pharmacy and Pharmaceutical Sciences